Stock Scorecard
Stock Summary for AMGEN Inc (AMGN) - $297.89 as of 10/3/2025 8:53:26 PM EST
Total Score
12 out of 30
Safety Score
72 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for AMGN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AMGN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AMGN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AMGN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AMGN (72 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AMGN
Financial Details for AMGN
Company Overview |
|
|---|---|
| Ticker | AMGN |
| Company Name | AMGEN Inc |
| Country | USA |
| Description | Amgen Inc. is a leading multinational biopharmaceutical company headquartered in Thousand Oaks, California, specializing in the development, manufacture, and commercialization of innovative therapies based on recombinant DNA technology. With a strong commitment to molecular biology and biochemistry, Amgen focuses on oncology, nephrology, and inflammation, delivering biologic products that significantly improve patient outcomes. As a pioneer in biotechnology with a robust pipeline and a strong market presence, Amgen continues to drive advancements in medicine while actively addressing unmet medical needs globally. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/29/2025 |
Stock Price History |
|
| Last Day Price | 297.89 |
| Price 4 Years Ago | 199.53 |
| Last Day Price Updated | 10/3/2025 8:53:26 PM EST |
| Last Day Volume | 2,516,093 |
| Average Daily Volume | 2,383,227 |
| 52-Week High | 330.26 |
| 52-Week Low | 247.06 |
| Last Price to 52 Week Low | 20.57% |
Valuation Measures |
|
| Trailing PE | 24.30 |
| Industry PE | 26.58 |
| Sector PE | 41.81 |
| 5-Year Average PE | 15.71 |
| Free Cash Flow Ratio | 19.98 |
| Industry Free Cash Flow Ratio | 38.57 |
| Sector Free Cash Flow Ratio | 30.43 |
| Current Ratio Most Recent Quarter | 1.31 |
| Total Cash Per Share | 14.91 |
| Book Value Per Share Most Recent Quarter | 13.80 |
| Price to Book Ratio | 21.63 |
| Industry Price to Book Ratio | 10.68 |
| Sector Price to Book Ratio | 32.30 |
| Price to Sales Ratio Twelve Trailing Months | 4.59 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.95 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.26 |
| Analyst Buy Ratings | 10 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 538,362,000 |
| Market Capitalization | 160,372,656,180 |
| Institutional Ownership | 84.13% |
Dividends |
|
| Ex-Dividend Date | 8/22/2025 |
| Previous Dividend Amount | 2.3800 |
| Current Dividend Amount | 2.3800 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 9.39 |
| Trailing Annual Dividend Yield | 3.15% |
| Forward Annual Dividend Rate | 9.52 |
| Forward Annual Dividend Yield | 3.20% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 3.54% |
| 5-Year Average Dividend Yield | 3.36% |
| 1-Year Dividend Growth Rate Percentage | 5.78% |
| 3-Year Dividend Growth Rate Percentage | 2.85% |
| 5-Year Dividend Growth Rate Percentage | 7.84% |
| All-Time Dividend Growth Rate Percentage | 16.50% |
| Dividend Payout Ratio | 76.72% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 92.00% |
| Annual Earnings Growth | -39.11% |
| Reported EPS 12 Trailing Months | 12.24 |
| Reported EPS Past Year | 10.92 |
| Reported EPS Prior Year | 19.82 |
| Net Income Twelve Trailing Months | 6,619,000,000 |
| Net Income Past Year | 4,090,000,000 |
| Net Income Prior Year | 6,717,000,000 |
| Quarterly Revenue Growth YOY | 9.40% |
| 5-Year Revenue Growth | 7.43% |
| Operating Margin Twelve Trailing Months | 32.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 8,028,000,000 |
| Total Cash Past Year | 11,973,000,000 |
| Total Cash Prior Year | 10,944,000,000 |
| Net Cash Position Most Recent Quarter | -45,732,000,000 |
| Net Cash Position Past Year | -44,576,000,000 |
| Long Term Debt Past Year | 56,549,000,000 |
| Long Term Debt Prior Year | 63,170,000,000 |
| Total Debt Most Recent Quarter | 53,760,000,000 |
| Equity to Debt Ratio Past Year | 0.09 |
| Equity to Debt Ratio Most Recent Quarter | 0.12 |
| Total Stockholder Equity Past Year | 5,877,000,000 |
| Total Stockholder Equity Prior Year | 6,232,000,000 |
| Total Stockholder Equity Most Recent Quarter | 7,428,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 10,605,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 19.70 |
| Free Cash Flow Past Year | 10,394,000,000 |
| Free Cash Flow Prior Year | 7,359,000,000 |
Options |
|
| Put/Call Ratio | 0.41 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -2.36 |
| MACD Signal | -2.65 |
| 20-Day Bollinger Lower Band | 268.09 |
| 20-Day Bollinger Middle Band | 286.40 |
| 20-Day Bollinger Upper Band | 304.70 |
| Beta | 0.48 |
| RSI | 39.18 |
| 50-Day SMA | 285.64 |
| 150-Day SMA | 267.84 |
| 200-Day SMA | 254.27 |
System |
|
| Modified | 10/3/2025 5:11:49 PM EST |